Patient ‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 trial

CONCLUSIONSThis de‐escalation regimen achieved QOL outcomes that were favorable compared with historical controls. These results serve as powerful evidence that ongoing de‐escalation efforts lead to tangible gains in function and QOL. Cancer 2017. © 2017 American Cancer Society.

Source: Cancer - October 17, 2017 Category: Cancer & Oncology Authors: John V. Hegde, Narek Shaverdian, Megan E. Daly, Carol Felix, Deborah L. Wong, Michael H. Rosove, Jordan H. Garst, Pin ‐Chieh Wang, Darlene Veruttipong, Shyam Rao, Ruben C. Fragoso, Jonathan W. Riess, Michael L. Steinberg, Allen M. Chen Tags: Original Article Source Type: research